TORONTO, ON / ACCESSWIRE / June 29, 2020 / Vanadium One Iron Corp. (the "Company") (TSXV:VONE), is pleased to announce the appointment of Mr. Norman Steinberg as Strategic Advisor to the Company. Mr. Steinberg is a highly distinguished Quebec based lawyer and an esteemed member of the Quebec business & philanthropic community. Mr. Steinberg served as Global Chairman of Norton Rose Fulbright, one of the world's top 10 legal firms, which combined with Ogilvy Renault in June 2011 while Mr. Steinberg was Chairman. In addition, Mr Steinberg has a long history focused on corporate governance, participation with public, private, family and not-for-profit boards and their various committees including Audit, Compensation and Governance. Mr Steinberg has acted in a leadership role as legal advisor for some of the most important business transactions in Canada and globally, and has acted as a legal/business advisor to many corporate boards and committees. Mr Steinberg is currently the Vice-Chair of BFL Canada, the largest employee owned and operated commercial broker and consulting services firm in Canada.

In addition, the Board of Directors is pleased to announce that Mr. Kurt Menchen has agreed to join the Company's Advisory Board to support the ongoing development of the Mont Sorcier project. Mr. Menchen has over 37 years of experience operating and managing mining projects, including over 20 years as General Manager at the Jacobina Gold project in Bahia State, Brazil. In addition, Mr. Menchen played a major roll in the definition, evaluation, construction and operation of Largo Resources Maracas Menchen vanadium mine in Brazil as Chief Operating Officer. His prior experience includes Anglo American's Vaal Reefs underground gold mine in South Africa and De Beers Goldfields in Angola. Mr. Menchen holds a degree in mining engineering from Federal University of Rio Grande do Sul, Brazil.

Mark Brennan, Executive Chairman commented, "We are delighted to have Norman join our efforts to bring the Mont Sorcier project to fruition. We believe that Norman will be an invaluable advocate in Quebec aiding Vanadium One in negotiating with government, regulatory and environmental bodies to ensure Mont Sorcier is developed in a world class fashion. We are also very pleased to have Kurt join the Advisory Board given his extensive history and our partnership in developing projects around the world."

In addition, the Company announces that the Board of Directors has approved the granting of stock options to Mr. Steinburg and Mr. Menchen under the Company's Stock Option Plan to acquire an aggregate of 400,000 common shares of the Company, exercisable at C$0.10 per common share, for a period of 2 years from June 24, 2020. Vesting is immediate.

As of June 24, 2020 the Company is pleased to announced that it has filed its audited year end MD&A and Financial Statements on SEDAR.

About Vanadium One Iron Corp.:

Vanadium One Iron Corp. is a mineral exploration company headquartered in Toronto, Canada. The Company is focused on advancing its Mont Sorcier, Vanadium-rich, Magnetite Iron Ore Project, in Chibougamau, Quebec. The goal is to continue defining the extent of this resource and demonstrate its economic viability.

ON BEHALF OF THE BOARD OF DIRECTORS OF VANADIUM ONE IRON CORP.

Cliff Hale-Sanders, President & CEO
Tel: 416-819-8558
info@vanadiumone.com
www.vanadiumone.com

Cautionary Note Regarding Forward-Looking Statements:

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains "forward-looking information" including statements with respect to the future exploration performance of the Company. This forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements of the Company, expressed or implied by such forward-looking statements. These risks, as well as others, are disclosed within the Company's filing on SEDAR, which investors are encouraged to review prior to any transaction involving the securities of the Company. Forward-looking information contained herein is provided as of the date of this news release and the Company disclaims any obligation, other than as required by law, to update any forward-looking information for any reason. There can be no assurance that forward-looking information will prove to be accurate and the reader is cautioned not to place undue reliance on such forward-looking information.

SOURCE: Vanadium One Iron Corp.

ReleaseID: 595378

FLORHAM PARK, NJ / ACCESSWIRE / June 29, 2020 / Hisamitsu America, the marketers of Salonpas®, announce today that The Journal of Pain Research, an international, peer-reviewed scientific journal focusing on pain research and the prevention and management of pain, features the publication, in June 2020, of the RELIEF study: "Relieving Pain: Evaluating Patient Quality of Life Improvement – Perceptions, Experience and Feedback After Use of a Topical Pain Relief Patch," an exploratory pain management study, conducted by Clarity Science.

The comprehensive Institutional Review Board (IRB)-approved study evaluated whether a topical analgesic pain-relieving patch containing methyl salicylate (10%), Menthol (6%) and Camphor (3.1%) could reduce pain severity and improve function in patients with mild-to-moderate arthritic, neurological or musculoskeletal pain as compared to oral over-the-counter (OTC) agents (e.g., ibuprofen, naproxen, acetaminophen, and other pain medications such as creams, gels, roll-ons, sprays, patches or rubs, prescription NSAIDs (e.g., ibuprofen, naproxen, celecoxib, meloxicam or diclofenac), prescription opioids (e.g., fentanyl, hydrocodone, hydromorphone, morphine or oxycodone), or prescription anticonvulsants (e.g., gabapentin or pregabalin).

The treatment group for the RELIEF study included 152 adult patients with arthritis, neurological, or musculoskeletal pain who received the Salonpas® Pain Relieving Patch for 14 days. A control group included 47 patients who did not receive the patch – 34 of whom crossed over to evaluate their response to patch treatment as well.

Pain severity in treated patients decreased significantly, by 49.0% compared to 12.3% in patients in the control group, while function significantly improved by 58.1% compared to 14.8% in patients in the control group. Additionally, no side effects of treatment were reported. Also, at day 14, 60.5% of the treated patients were using concomitant oral pain medications a lot less and 90.8% of patients were very or extremely satisfied with the patch. Patients in the crossover group showed similar reductions in pain severity and improvement in function.

"Clinical treatment guidelines increasingly recommend the first-line use of topical analgesics, largely based on safety concerns associated with oral medications such as oral NSAIDs, acetaminophen, opioids, and anticonvulsants, which require substantial systemic exposure in order to have their therapeutic effect and pose associated risk of serious adverse events," said Dr. Jeffrey Gudin, the Principal Investigator of the RELIEF study who is board certified in pain management, anesthesiology, addiction medicine and palliative care. Dr. Gudin is affiliated with Englewood Hospital Medical Center and Rutgers New Jersey Medical School, Dept. of Anesthesiology, and is an author, researcher and opinion leader in pain management. "The RELIEF study not only supported the safety of this multimodal topical analgesic (Salonpas Pain Relieving Patch), it also supported the treatment's significant pain relieving effect in patients with mild to moderate pain, its favorable impact on function, and illustrated that its use reduced the use of oral NSAIDs, acetaminophen, opioids, and anticonvulsants."

"Our mission is to provide people in pain with clinically proven topical analgesics and practitioners with the clinical proof they need to confidently recommend our products for their patients," said John Incledon, the President of Hisamitsu America Inc. "Prior to the RELIEF study, Hisamitsu supported the clinical evaluation of another one of it products, the Salonpas® Pain Relief Patch LARGE. The study was a well-controlled clinical study involving 208 patients with mild to moderate pain. Patients treated with the product experienced significantly more pain relief versus patients treated with a placebo patch and the majority of patients rated satisfaction with the product as good, very good, or excellent. This study ultimately supported an FDA approval of a New Drug Application for the product, making it not only the first FDA approved OTC topical analgesic, but also the only OTC pain reliever, systemic or topical, that is approved to treat mild and moderate pain. We will continue to provide people in pain and health care practitioners with clinical proof of the efficacy and safety of our products, so stay tuned for more news to come."

Oral pain relievers, mainly opioids, NSAIDs and acetaminophen are leading causes of serious adverse events (SAE's); addiction, hospitalization for CV & GI risk, liver toxicity, and death. The Center for Disease Control (CDC) reports that since 2000, over 200,000 people in the USA have died from overdose of prescription opioids. In 2016, the CDC issued guidance to physicians managing chronic pain without opioids, that topical analgesics can be an alternative first line therapy.

Based in Narragansett, Rhode Island, Clarity Science, LLC conducts scientifically rigorous and valid research that advances innovation in science and ultimately helps healthcare professionals provide improved patient care, leading to improved patient health worldwide.

Hisamitsu America provided a grant to Clarity Science to administer and conduct the IRB-approved study to collect data on patient outcomes for Quality of Life (QoL) components, pain relief scores and assessment of severity of pain and its impact on functioning, patient satisfaction, and an evaluation of differences, reported medical conditions and other prescribed or OTC oral medications commonly associated with pain.

About Hisamitsu America:

Hisamitsu America is the US division of Hisamitsu Pharmaceutical Co., Inc., founded in 1847, which has specialized in transdermal drug delivery system technology since the introduction of its Salonpas line of patches in 1934. The Salonpas® product line, which gained early acceptance in Asia and is now registered in over 30 countries, has pioneered the development of transdermal patches to relieve pain. Since 2010, Salonpas has become one of the fastest growing OTC brands in the USA. The Salonpas Pain Relief Patch LARGE holds the distinction of being the first topical analgesic approved OTC by the FDA and the only one to be approved for the treatment of mild to moderate pain. Salonpas became the most popular pain relief brand on Facebook in 2020. For more information, https://us.hisamitsu/.

# # #

Media Contact:

Nancy Thompson, Vorticom, Inc.
212.532.2208 (o)
917-371-4053 (m)
nancyt@vorticom.com

SOURCE: Hisamitsu America

ReleaseID: 595344

Rising agricultural activities due to expanding population in developing countries is bolstering usage of fatty amines, particularly in agrochemicals. This is due to the increasing number of mouths to feed in the future. As land under food cultivation increases, manufacturers are in a position to generate more profits in the agro-chemical sector.

DUBAI / ACCESSWIRE / June 29, 2020 / Future Market Insights The global fatty amines market is all set to surpass the US$ 2 Bn mark by the end of 2020, projects future market insights in its report. Market growth is being driven by widespread applications across a number of industries including water treatment, agro-chemicals and asphalt additives. Besides, proliferation of novel applications such as detergents, paints & coatings, fabric softener, and mining are also pulling up fatty amines market growth.

Fatty amines are largely consumed in the paints and coatings industry as additives to protect the paints from getting tainted while under storage. Based on such widespread usage, the fatty amines market is anticipated to continue generating high revenue in the coming future as well. However, the coronavirus pandemic is anticipated to induce a certain degree of stagnation in the market, attributed to restricted production cycles and diminishing output.

"Surging popularity of fatty amines as an important raw ingredients across end-use industries is motivating key market players to introduce novel formulations. Market players are leaving no stone unturned to accelerate research and development in this direction," says a prominent FMI analyst.

Request a report sample with 152 pages to gain in-depth insights on https://www.futuremarketinsights.com/reports/sample/rep-gb-361

Global Fatty Amines Market- Key Takeaways

The global fatty amines market expanded moderately at a CAGR of 4.2% between 2015 and 2020.
Tertiary fatty amines captured nearly half of the global fatty amines market, exhibiting a modest CAGR during the forecast period.
Asia-Pacific excluding Japan dominated the global fatty amines market in terms of region. Rapidly expanding automobile production in China is attributed as the major reason for growth.
However, North America and Western Europe emerged as high-ranking regions with CAGRs of 6.4% and 5.3% respectively.

Global Fatty Amines Market- Prominent Drivers

Burgeoning demand for water treatment products wherein fatty amines are used as corrosion inhibitors, disinfectants and biocides is catapulting the fatty amines market to greater heights.
Increased adoption in the construction industry attributed to good adhesive properties has accelerated its usage as an agent to bind asphalt and mineral aggregates.

Global Fatty Amines Market- Key Constraints

Volatile raw material prices and uncertainties in the availability of fatty amines is hampering the expansion of the global fatty amines market.
Governments world over have imposed strict guidelines regarding fatty amines usage due to claims of it having cancerous effects on human beings.

Anticipated Coronavirus Outbreak Impact

The coronavirus pandemic has led to a massive economic downturn across major end-use industries. The impact of the pandemic on the fatty amines market has varied as per the impact on its end-use industries. For instance, the agrochemical industry has been under doldrums, ranging from raw material supplies to availability of finished products. China is a major producer of active ingredients utilized in manufacturing agrochemicals as well as ready-made pesticides that are available across the world. Being the epicenter of the pandemic, the Chinese factories are anticipated to remain shut for an indefinite time period. Additionally, countries dependent on Chinese agrochemicals are also facing severe crunches as imports and exports have been curbed. The imposition of lockdowns have forced factory workers to go into self-isolation, leading to a shortage of labor. Based on these developments, the fatty amines market in the agrochemicals sector has witnessed a sharp decline.

Similarly, the construction industry has suffered significant losses due to the pandemic. Mandatory social distancing measures have compelled construction companies to urge its employees to remain indoors, as they are especially at a high risk of contracting the deadly virus through contact. Consequently, all activities have ceased, leading to a decline in the demand for fatty amines as asphalt additives. However, a silver lining exists for the cosmetics industry, wherein fatty amines are used as an important ingredient, driven by rising interest in sustainable chemicals in cosmetic products. Although first-quarter sales were weak in the wake of widespread store closures, vendors are reorienting their product portfolios to include hand sanitizers and offering free beauty services for frontline responders. Moreover, they have effectively leveraged online platforms to make their products accessible to customers, helping it stay afloat. These trends point towards a bright future for fatty amines in the cosmetics industry.

Explore the fatty amines market report with numerous illustrative figures, data tables and the table of contents. You can also find a detailed market segmentation at https://www.futuremarketinsights.com/askus/rep-gb-361

Competition Landscape

The global fatty amines market is characterized by the presence of the following market players: Lonza, Clariant AG, Sigma-Aldrich Corporation, Kao Corporation, CECA Arkema Group, Procter & Gamble Chemicals Company, Evonik Industries AG, AkzoNobel N.V, DuPont and Volant-Chem Group. Heavy investments in research & development to develop new products is proving beneficial to the abovementioned market players and offering them profitable opportunities in the future. Increasing volume of business attributed to the presence of a multitude of market players has enhanced market competitiveness, prompting increasing collaborations, product launches and expansion into new geographies to secure a foothold.

More about the Fatty Amines Market

FMI's research report on the fatty amines market provides an unbiased analysis on the key market dynamics such as the drivers, restraints and opportunities associated with the growth of the market. The analysis has been provided in detail based on two major segments: product type and application. By product type, the market is segmented into primary fatty amines, secondary fatty amines and tertiary fatty amines. On the basis of application, the market is divided into water treatment chemicals, agro-chemicals, oilfield chemicals, asphalt additives, anti-caking and others (personal care, mining, fabric softener, paints & coatings). All these segments are analyzed across the following geographies: North America, Western Europe, Eastern Europe, Asia-Pacific Excluding Japan (APEJ), Japan, Latin America and Middle East & Africa (MEA).

Explore FMI's Extensive Insights on the Chemicals & Materials Landscape

Sulfur Hexafluoride Market: FMI's report on the sulfur hexafluoride market elaborates on vital market dynamics, including growth drivers, opportunities and challenges for the forecast period 2019-2029.

Refinery Catalyst Market: Explore how the surging popularity of refinery catalysts is assisting market players and governments in curbing greenhouse gas emissions from the oil & gas sector in FMI's detailed research report for the period 2020-2027.

Bentonite Market: The bentonite market research report compiled by FMI offers in-depth insights regarding the vital growth dynamics, segmental-analysis across key regions and market competitiveness for the forecast period 2019-2029.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/fatty-amines-market

Press Release Source: https://www.futuremarketinsights.com/press-release/fatty-amines-market

SOURCE: Future Market Insights

ReleaseID: 595565

ATLANTA, GA / ACCESSWIRE / June 29, 2020 / Findit, Inc. a Nevada Corporation (OTC Pink:FDIT) owner of Findit.com, a full service social networking management platform and online marketing service, has been retained by Global WholeHealth Partners (OTC Pink:GWHP) to improve overall web presence.

Findit will produce fresh content on a daily basis highlighting Global WholeHealth Partners products and technology to reach wholesale, retail and distributors of PPE products along with Diagnostic Test Kits around the world.

Charles Strongo CEO of Global WholeHealth Products since 2103 stated "We selected Findit after consulting with a number of other online marketing firms. With Findit's open platform the content they create will be able to be indexed in Google and shared to popular social networking sites that include Facebook, LinkedIn, Twitter, Tumblr and others. Findit understands our focus which is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. We want Findit to help us get our message throughout the world during these times to reach people that need testing. We hope that by focusing on the growth of our global core business that includes our plethora of test kits and medical supplies we will provide confidence to our existing shareholders in GWHP and new shareholders that acquire stock in GWHP. We want our shareholder to know GWHP is focused on growth through sales and development of new testing kits to help combat growing health concerns around the world."

Global Wholehealth Partners (OTC Pink:GWHP) has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases.

Findit will be providing Global WholeHealth Partners with content creation through at least three Findit sites owned by Global WholeHealth Partners. With the content, Findit will create this will provide a understanding of what Global WholeHealth Partners offers to wholesale, retail and distributors that are selling PPE products that include; surgical masks, disposable rubber gloves, disposable CPE Shoe Covers and No Touch Infrared Thermometers and Diagnostic Test Kits.

Over the first 30 days, Findit will create, post and share over 200 pieces of freshly written content from Global health Partners profile sites on Findit.com. The content created will consist of Right Now status updates. Once the posts are live, they can be shared to other social networking sites that include but are not limited to: Facebook, LinkedIn, Pinterest, Tumblr and Twitter. Each post will consist of a description of the products offered by Global Wholehealth Partners.

In addition to the text written, each piece of content will also include pictures that have titles that we have manually entered for indexing purposes in Findit search as well as outside search engines that include Google, Yahoo and Bing. Findit also includes a back link to specific pages that will drive traffic to www.gwhpcorp.com.

The overall objective of the campaign is to bring awareness to Global WholesaleHealth Partners (GWHP) so they can increase sales by reaching new and existing customers of their products. GWHP.com current Alexa Ranking is 2,965,383 In global internet traffic and engagement over the past 90 days. Clark St. Amant of Findit stated, "Being selected by GWHP during Covid-19 is something we are taking on with great responsibility. We want to carry their message to reach as many people in need of the products GWHP carries. With so much demand for masks, gloves, thermometers, shoe covers products GWHP carries, many buyers are scrabbling over the past few months to find reliable suppliers that they can count on beyond one order due to lack of inventory. GWHP has over 3 million masks currently in stock in the U.S. With the team at Findit getting this information out to the public we are hopeful that we can contribute to the safety of first responders and citizens that are simply trying to do their best to adapt to these times we are now in and remain healthy."

Findit will be providing a site analysis of GWHP.com in addition to the campaign. The analysis will look at Search Engine Optimization (SEO) opportunities to present GWHP.com with. After the analysis is provided this week GWHP can decide if it would like Findit, Inc. to provide these SEO services.

The campaign is officially kicking off today, June 29, 2020. Below are several Findit sites that have been created for GWHP, that content will be posted and shared through. Each post will have a back link to GWHPCORP.COM.

GWHP has 3 Findit Claim Your Name URLs these are:

PPE-MASK-GLOVES-THERMOMETERS

COVID-19-DIAGNOSTIC-TESTS

GWHP-CORP

Call 1-877-568-GWHP (4947) to become a distributor or buy COVID 19 rapid test rt-qPCR kits. We offer small sample size test kits, sold in packs of 100.

About Global Wholehealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 – 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.

About Findit, Inc.
Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTC Pinksheets.

Download the Findit App today in Google or Apple today.

Google Play Findit App

App Store Apple Findit Right Now App

Safe Harbor:

This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.

CONTACT:

Clark St. Amant 404-443-3224

SOURCE: Findit, Inc

ReleaseID: 595526

DIDCOT, UK / ACCESSWIRE / June 29, 2020 / Altus Strategies Plc (AIM:ALS)(TSXV:ALTS) (‘'Altus'' or the ‘'Company''), the mining royalty company generating a diversified and precious metal focused portfolio of assets through discovery, investment and acquisition, announces that it has signed a non-binding Term Sheet ("Term Sheet") with TSX-V listed Stellar Africa Gold Inc. ("Stellar") for the sale of and royalties on Altus' Prikro and Zenoula gold projects ("Projects") located in the Republic of Côte d'Ivoire ("Ivory Coast").

Highlights:

Term Sheet for sale of a 100% interest in two Ivory Coast gold projects (the "Transaction")
Altus will receive an initial payment of:

2,500,000 Stellar shares with a current market value of C$87,500 and 2,500,000 share purchase warrants, each exercisable to purchase a Stellar share for 24 months at C$0.07
A 2.5% Net Smelter Return ("NSR") royalty on the Projects

Subject to the progress of the Projects, Altus will receive further equity based payments
The Transaction remains subject to 30 days due diligence, definitive Sale & Purchase and Royalty Agreements ("Agreements"), TSX-V approval and other conditions precedent

Steven Poulton, Chief Executive of Altus, commented:

"We are pleased to announce the signing of this non-binding Term Sheet with Stellar for the sale of our prospective Prikro and Zenoula gold projects in Ivory Coast. We believe that the proposed Transaction not only validates the value we have identified in the Projects but that we have partnered with the right company to progress these Projects through to the next key phases."

"Our focus remains firmly on delivering a high quality, diversified and precious metal focused portfolio of assets to our shareholders. This proposed Transaction further underscores our dynamic and highly effective royalty generating business model and we look forward to updating shareholders on this opportunity in due course."

Transaction Terms

Subject to entering into the Agreements with Altus and TSX-V approval, Stellar will earn a 100% interest in Aeos Resources Ltd ("Aeos"), a wholly owned Seychelles incorporated subsidiary of the Company. Through its Ivorian subsidiary Aucrest SARL, Aeos holds a 100% interest in the Projects. The Term Sheet is subject to exclusivity provisions for 30 days following signing. The Agreement will have the following headline terms:

Part 1: Consideration

Upon signing of the Agreements by the Parties, Stellar will:

Within 14 days and subject to any regulatory or shareholder approvals as may be required, issue 2,500,000 Units of Stellar to Altus. Each Unit will consist of one Stellar share and one 24 month share purchase warrant, with each warrant granting the holder the right but not the obligation to purchase one Stellar share at a price of C$0.07.

Part 2: Milestone payments

Upon the definition of a resource, confirmed by an independent NI 43-101 report, which exceeds 500,000 ounces of gold (including at least 250,000 ounces within the Indicated category), Stellar will (in respect of the first 500,000 ounces on each Project):

Within 14 days and subject to any regulatory or shareholder approvals as may be required, issue Stellar shares valued (at the time of issuance) at US$250,000 to Altus.

Upon the completion of a definitive feasibility study on either Project, Stellar will:

Within 14 days and subject to any regulatory or shareholder approvals as may be required, issue Stellar shares valued (at the time of issuance) at US$250,000 to Altus.

Part 3: Project Royalties

Altus will retain a 2.5% NSR royalty on each of the Projects.
Stellar will have the right to repurchase up to 1.0% of each NSR for US$0.5 million for each 0.5% repurchased.

Prikro Project

The Prikro project comprises a single 369.5 km2 exploration licence in the Prikro and Koun-Fao Departments in eastern Ivory Coast, approximately 240km northeast of the capital of Abidjan. The project is located 40km north-west of the town of Agnibilekrou and 25km west of the town of Koun-Fao, both of which can be accessed by asphalt roads from Abidjan. The licence was selected due to the presence of historically reported gold occurrences, prospective geology, and the existence of artisanal workings in the surrounding areas including along strike of a major NE-SW trending shear zone which is interpreted to traverse the licence area. Birimian-age greenstone rocks reportedly crop out extensively across the Prikro licence and represent Paleoproterozoic meta-sedimentary units, with associated granite to diorite intrusives, which are the dominant host setting for gold deposits across West Africa.

Zenoula Project

The Zenoula project comprises a single 400km2 licence application which is currently pending grant in the Marahoue Department in central Ivory Coast, approximately 300km north of Abidjan. The project is located 100km north-west of the city of Yamoussoukro which can be accessed by asphalt roads from Abidjan. Zenoula is centred within a NNE trending Birimian age granite greenstone belt, 65km along strike from the Abujar project of ASX listed Tietto Minerals Limited. Mineralization hosted on this property is not necessarily indicative of the Zenoula project. Zenoula targets a 22 km long oblique ENE trending structure, interpreted by historic air magnetic data. Geologically, the project reportedly comprises metasediments, metabasalts and syntectonic granitoid intrusives.

Qualified Person

The technical disclosure in this regulatory announcement has been read and approved by Steven Poulton, Chief Executive of Altus. A graduate of the University of Southampton in Geology (Hons), Steven Poulton also holds a Master's degree from the Camborne School of Mines (Exeter University) in Mining Geology. He is a Fellow of the Institute of Materials, Minerals and Mining and has over 20 years of experience in mineral exploration and is a Qualified Person under the AIM rules and National Instrument 43-101 Standards of Disclosure of Mineral Projects of the Canadian Securities Administrators.

For further information you are invited to visit the Company's website www.altus-strategies.com or contact:

Altus Strategies Plc
Steven Poulton, Chief Executive
Tel: +44 (0) 1235 511 767
E: info@altus-strategies.com

SP Angel (Nominated Adviser)
Richard Morrison / Soltan Tagiev
Tel: +44 (0) 20 3470 0470

SP Angel (Broker)
Abigail Wayne / Richard Parlons
Tel: +44 (0) 20 3470 0471

Yellow Jersey PR (Financial PR & IR)
Georgia Colkin / Charles Goodwin / Henry Wilkinson
Tel: +44 (0) 20 3004 9512
E: altus@yellowjerseypr.com

About Altus Strategies Plc

Altus Strategies is a London (AIM: ALS) and Toronto (TSX-V: ALTS) listed mining royalty company generating a diversified and precious metal focused portfolio of assets. The Company's focus on Africa and differentiated approach, of generating royalties on its own discoveries as well as through financings and acquisitions with third parties, has attracted key institutional investor backing. The Company engages constructively with all stakeholders, working diligently to minimise its environmental impact and to promote positive economic and social outcomes in the communities where it operates. For further information, please visit www.altus-strategies.com.

Cautionary Note Regarding Forward-Looking Statements

Certain information included in this announcement, including information relating to future financial or operating performance and other statements that express the expectations of the Directors or estimates of future performance constitute "forward-looking statements". These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include without limitation the completion of planned expenditures, the ability to complete exploration programmes on schedule and the success of exploration programmes. Readers are cautioned not to place undue reliance on the forward-looking information, which speak only as of the date of this announcement and the forward-looking statements contained in this announcement are expressly qualified in their entirety by this cautionary statement.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. The forward-looking statements contained in this announcement are made as at the date hereof and the Company assumes no obligation to publicly update or revise any forward-looking information or any forward-looking statements contained in any other announcements whether as a result of new information, future events or otherwise, except as required under applicable law or regulations.

TSX Venture Exchange Disclaimer

Neither the TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

Market Abuse Regulation Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR") until the release of this announcement.

Glossary of Terms
The following is a glossary of technical terms:

"Artisanal" means local people conducting mining, often with rudimentary equipment
"km" means kilometre
"NI 43-101" means National Instrument 43-101 "Standards of Disclosure for Mineral Projects" of the Canadian Securities Administrators
"Qualified Person" means a person that has the education, skills and professional credentials to qualify as a qualified person under NI 43-101

"Shear zone" means a zone in which rocks have been deformed by lateral movement along parallel planes

SOURCE: Altus Strategies PLC

ReleaseID: 595495

The debt issuance has been executed in accordance with the terms of the Debenture contained in the Company's 10-Q through the issuance of common shares in order to preserve cash available to fund ongoing operations.

As the US economy improves and physicians' offices re-open the Company foresees its cGMP laboratory processing cellular samples by late summer despite the Covid-19 pandemic and its associated shutting down of the American economy.

EATONTOWN, NJ / ACCESSWIRE / June 29, 2020 / American CryoStem Corporation (OTC PINK:CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular products and technologies for the Regenerative and Personalized Medicine industries today announced that $168,000 of the Company's convertible debt that was recorded in the March 31, 2020 10-Q balance sheet of CRYO has been successfully converted into equity. John Arnone CEO of CRYO stated, "This debt conversion and subsequent sale into the marketplace relieves significant overhang pressure that we believe has depressed our stock price."

The Company is projecting that its revenue and margins will begin to resume this summer despite the economic downturn during 2020 and as certain Company initiatives come to fruition the Company will be in a position to raise institutional capital late 2020. Additionally, the Company believes that its Investigational New Drug (IND) may be approved in 2020.

The volatility of the market is unprecedented and the Company will act to preserve and continue to grow shareholder value.

For further detailed Corporate or Regenerative Medicine information please visit:

www.americancryostem.com, request by email at info@americancryostem.com or phone 732-747-1007

This press release may contain forward-looking statements, including information about management's view of American CryoStem Corporation's ("the Company") future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this press release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by American CryoStem Corporation.

SOURCE: American CryoStem Corporation

ReleaseID: 595533

GUILDFORD, UK / ACCESSWIRE / June 29, 2020 / Linde (NYSE:LIN)(FWB:LIN) has been upgraded to A in MSCI's ESG Ratings assessment, on a scale of CCC to AAA. The improvement from BBB was mainly attributed to the company's comprehensive decarbonization strategy, including its initiatives to reduce its greenhouse gas emissions intensity by 35% and double the annual purchase of renewable power by 2028.

MSCI ESG Ratings measure companies according to industry-specific exposure to environmental, social and governance (ESG) risks and their ability to manage them.

"Linde is helping its customers to avoid more than two times the emissions of our own operations through the application of our technologies and solutions," said Riva Krut, Vice President and Chief Sustainability Officer at Linde. "We appreciate this upgrade as we continue developing our leading position and technologies in fields such as clean hydrogen, and making our world more productive."

In addition to its upgrade from MSCI, Linde recently received several recognitions for its leadership in ESG including Silver Class distinction in The Sustainability Yearbook 2020, published by S&P Global in collaboration with RobecoSAM, and inclusion in the 100 Best Corporate Citizens 2020 list. Linde is a member of the Ethibel Sustainability Index, the Dow Jones Sustainability World Index and the FTSE4Good Index Series.

About Linde

Linde is a leading global industrial gases and engineering company with 2019 sales of $28 billion (€25 billion). We live our mission of making our world more productive every day by providing high-quality solutions, technologies and services which are making our customers more successful and helping to sustain and protect our planet.

The company serves a variety of end markets including chemicals & refining, food & beverage, electronics, healthcare, manufacturing and primary metals. Linde's industrial gases are used in countless applications, from life-saving oxygen for hospitals to high-purity & specialty gases for electronics manufacturing, hydrogen for clean fuels and much more. Linde also delivers state-of-the-art gas processing solutions to support customer expansion, efficiency improvements and emissions reductions.

For more information about the company and its products and services, please visit www.linde.com.

Contacts:
 

Investor Relations
Juan Pelaez
Phone: +1 203 837 2213
Email: juan.pelaez@linde.com
Media Relations
Anna Davies
Phone: +44 1483 244705
Email: anna.davies@linde.com

SOURCE: Linde plc

ReleaseID: 595567

BIRMINGHAM, AL / ACCESSWIRE / June 29, 2020 / London LSE-quoted Diversified Gas & Oil PLC (LSE:DGOC), the U.S. based owner and operator of natural gas, natural gas liquids, and oil wells as well as midstream assets, is pleased to announce that the Company's bank lending group, led by KeyBank National Association (the "Bank Group"), has completed the semi-annual redetermination of the Company's senior secured credit facility (the "Facility") and reaffirmed the existing $425 million borrowing base. The Bank Group also approved amendments enhancing the Company's hedging capabilities. There were no changes to pricing or covenant terms.

DGO expects to complete its next scheduled redetermination in the fourth quarter of 2020.

Following the redetermination, DGO's net debt approximates $756 million and current liquidity approximates $213 million, comprised of cash on hand and availability under the Facility. The Company's current borrowings result in a Net Debt to EBITDA ratio of approximately 2.2x(a), below stated targets and debt covenant thresholds.

Rusty Hutson, Jr., CEO of the Company commented,

"The reaffirmation of our borrowing base in this challenging environment speaks to the quality of our production, reserves and our strategy that is focused on generating steady positive cash flow to reduce debt and maintain a healthy balance sheet while consistently returning cash to shareholders through the dividend. This redetermination, together with other financings completed this year, demonstrates our ability to access competitive capital against a difficult economic backdrop. I would like to thank our 17-member bank group for their continued support as we remain focused on prudent growth in a market with increasing opportunities for those with an ability to transact and a proven record of successful execution."

Footnotes:

EBITDA is 2019 pro-forma for recent acquisitions as reflected in the 12 May 2020 Acquisition Presentation available at www.dgoc.com/presentations

Company Contact: Teresa Odom, VP Investor Relations | IR@dgoc.com | 205.408.0909

SOURCE: Diversified Gas & Oil Plc

ReleaseID: 595527

Fidentity now offers a touchless employee check-in process, temperature scanning, and PPE scanning to keep your workers safe and healthy. These features are added in addition to the existing touchless visitor management System and delivery management feature

FAYETTEVILLE, AR / ACCESSWIRE / June 29, 2020 / With the sudden outbreak of COVID-19, businesses must make changes to their regular operations. Fidentity, powered by Zenwork, Inc, is committed to the health and safety of your employees and visitors. One result of that commitment is the new additions to the Fidentity System. These new features enable organizations to create a safe and secure environment for anyone entering the workplace.

"As we saw the health risks multiply for anyone entering a place of business, we decided to speed up our implementation of several features we already had on the roadmap," said Sanjeev Singh, Founder, and CEO of Zenwork, Inc, the parent company of Fidentity. "The risk of endangering employee and visitor health has increased with the pandemic. As part of our mission to help companies achieve compliance through technology, we strongly feel these new features will aid companies in their goal to have a safe workplace for anyone who enters the building."

For more details Download Fidentity Brochure Now.

Fidentity's newly launched platform includes QR code and facial recognition based Touchless Employee Attendance, Visitor and Delivery Management System.
Touchless Employee Management System component that Fidentity added to the already robust Visitor Management Software (VMS). The Fidentity Visitor Management System with Employee Management consolidates employees and visitors into one centralized system, creating an automated process that is efficient and completely touchless.

In addition to newly added software features, ZenScan- Temperature Scanner with built-In Facial Recognition is Zenwork's latest hardware, incorporating AI-driven technology to combat COVID-19. Zenscan offers four features: temperature scanning, PPE scanning, facial recognition, and employee management software. These features increase safety precautions in the workplace and create an efficient touchless sign-in process for employees.

ZenScan checks everyone who enters the building for COVID-19 symptoms by conducting a forehead temperature scan, running facial recognition, and detecting if someone isn't wearing proper Personal Protective Equipment (PPE). ZenScan can be programmed to automatically deny or allow access into your workplace based on the employee being identified and passing the required health checks. Employees have the added benefit of being automatically clocked-in when they enter the building, with timestamps that sync to payroll.

For more information download Zenscan Brochure now!

Nick Bondurant, Product Director for Zenwork, said, "Since the beginning of the Covid-19 outbreak, we have used our resources to make rapid changes to Fidentity, knowing that companies can use our products to keep their workplace safe."

In addition to the Employee Management System features, Fidentity has added Delivery Management. The Delivery Management Software enables companies to handle incoming deliveries, delivery locations, delivery notifications, and reminders with ease. When a package arrives, the recipient will receive a notification alerting them to pick up their package. With the growth of delivery services and the need for employees who cannot be at home when a package arrives to receive their package without the fear of theft, Delivery Management System provides an efficient method for companies to permit employees to receive their packages at work instead of home.

The new Fidentity features will assist businesses small and large to remain in compliance with changing CDC recommendations while making life easier for their employees at the same time.

About Fidentity:

Fidentity.com is powered by Zenwork, Inc. is an AI-based Employee, Visitor, Delivery, and Event Management System which is cloud-based software designed to fully automate the check-in process for employees, visitors, delivery and event management. Fidentity will also track, store, and display employee and visitor information in real me. Fidentity allows organizations to create a customized touchless check-in process that maximizes visitor experience for everyone that enters the business.

Contact:
Name: Tim Johnson
Number 877-811-3829 – Option 7
Email: info@fidentity.com

SOURCE: ZENWORK INC

ReleaseID: 595556

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Migom Global Corp., (OTC PINK:MGOM) a US publicly traded company focused on building synergistic ventures in international banking, has recently notified the SEC of the acquisition of Migom Bank (www.migom.com), an international full-service "neobank" domiciled and regulated in the small Caribbean state of Commonwealth of Dominica.

"Today, businesses across multiple jurisdictions and industries have faced numerous hurdles opening and maintaining simple operating bank accounts. Arbitrarily frozen funds, suddenly blocked accounts, and other previously rare limitations have become a commonplace occurrence in daily banking for many regular businesses. This type of practice is often disguised as "de-risking" in the name of compliance, which in itself has morphed from the necessary but secondary function into a universal shroud weaponized by some of the mainstream banks in their purge of unwanted business," stated Thomas Schaetti, the President of Migom Global Corp. He continued: "In reality, those large international banks seem to be simply discriminating small and medium-sized, transaction-heavy businesses, which they don't see as a profitable market. As the result, millions of unbanked or under-banked entrepreneurs have a hard time growing their companies and contributing to the economic development of their industries and regions. We identify ourselves with these companies and are making our best effort to position Migom Bank as the destination financial institution serving their needs around the world".

Migom Global Corp. aims to bridge the gaps in international banking by building a network of banks and affiliated businesses to provide seamless integration of traditional regulated banking with new-age financial services and emerging fintech solutions. Committed to solving the problem of under-banked businesses and individuals worldwide, the Company recently notified the SEC of the acquisition of 100% of the shares of Migom Bank, a full-service global bank for the digital age that is available to customers across a variety of industries and regions.

Migom Bank offers a full suite of e-banking services tailored to the needs of small businesses and entrepreneurs, including online account opening, holding and operating corporate and individual bank accounts with full online access to account management and detailed reporting, international SWIFT / SEPA transfers in multiple currencies, issuing prepaid debit cards, certificates of deposit, investment, savings accounts and other services. The regulatory information enumerating multiple services provided by the bank is published on its website.

In addition to providing traditional banking services, Migom Bank offers its account holders one of a kind crypto-to-fiat and fiat-to-crypto OTC functionality, including secure custody and instant-execution trading of crypto assets with unlimited liquidity volumes, best global spot prices and immediate availability of funds or crypto assets. Migom Bank account holders can seamlessly transfer fiat funds into crypto assets and back using their mobile app or account dashboard online.

About Migom Global Corp.

Migom Global Corp. is a US publicly traded company (OTC PINK:MGOM) building synergistic ventures in international banking, securities brokerage, electronic money distribution as well as digital assets origination and market making. The Company is developing the network of affiliated businesses in several countries, which may provide a seamless integration between the traditional regulated banking and financial services and the innovative emerging fintech solutions, benefiting consumers and businesses worldwide.

About Migom Bank

Migom Bank is a global neobank focused on the emerging markets offering a full suite of e-banking services tailored for the needs of small-to-medium-sized businesses and entrepreneurs. Migom Bank is fully licensed to provide retail depository and inter-banking services, full suite of cryptocurrency-related services, securities dealing and investment banking services, featuring deal-oriented compliance, higher private banking limits and custom-tailored flexible solutions to help its versatile international clientele. For more information, please, visit http://migom.com.

Media contact
Company: Migom Bank
Contact: PR Department
E-mail: info@migom.com
Website: https://migom.com/

SOURCE: Migom Bank

ReleaseID: 595561